MedPath

investigation and Comparison of the effect of Daflon and pentoxifylline in the treatment of patients with chronic venous insufficiency

Phase 1
Recruiting
Conditions
Patients with chronic venous insufficiency.
Venous insufficiency (chronic) (peripheral)
I87.2
Registration Number
IRCT20221213056808N1
Lead Sponsor
Gorgan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Chronic venous insufficiency disease with class C2 and more according to CEAP criteria
Consent to take medicine
Ability to communicate

Exclusion Criteria

Patients who are candidates for surgery
Patients who do not take medicine

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CEAP( classification stands for Clinical (C), Etiological (E), Anatomical (A), and Pathophysiological (P)) Score. Timepoint: At the beginning of the study and 6 months after taking the drug. Method of measurement: C0: no obvious features of the disease: C1: spider veins C2: obvious varicose veins: C3: edema: C4: eczema and skin discoloration: C5: healing wounds C6: active wounds with exudation.;Venous Clinical Severity Score(vcss score). Timepoint: At the beginning of the study and 6 months after taking the drug. Method of measurement: Pigmentation: 0-2 Vascularity: 0-5 Pliability: 0-5 Height: 0-3.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath